ACE Report Cover
Intra-articular Injections of Hylan G-F 20 for Pain in Patients with Idiopathic Knee Osteoarthritis
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
OSTEOARTHRITIS
Intra-articular Injections of Hylan G-F 20 for Pain in Patients with Idiopathic Knee Osteoarthritis .

Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled tri

Drugs Context. 2024 01-Apr;():. 10.7573/dic.2023-11-3

Thirty patients with chronic idiopathic knee osteoarthritis (Larsen grade II or III) were randomized to receive three once-weekly intra-articular injections of either Hylan G-F 20 (n=15) or placebo (n=15). The primary outcome was pain relief as assessed by visual analogue scale (VAS) scores at weeks 12 and 26. Secondary outcomes included patient activity level, overall clinical condition, and adverse events. Follow-up occurred at multiple intervals up to 26 weeks. Overall, the study revealed that Hylan G-F 20 significantly improved patient-assessed and evaluator-assessed outcomes (p<0.0001), except for night pain and inactivity stiffness, with no significant safety concerns. These findings suggest that Hylan G-F 20 provides effective and sustained pain relief in this population.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Intra-articular Injections of Hylan G-F 20 for Pain in Patients with Idiopathic Knee Osteoarthritis. ACE Report. 2024;306(12):36. Available from: https://myorthoevidence.com/AceReport/Show/intra-articular-injections-of-hylan-g-f-20-for-pain-in-patients-with-idiopathic-knee-osteoarthritis

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report